Economic growth begins with ideas, innovation and creativity. Since the signing of the Constitution, the U.S. has protected the fruits of creativity and innovation through intellectual property protection, primarily expressed as patents, trademarks, copyright and trade secrets.
As our economy has become even more dependent on innovation, intellectual property issues have been pushed to the forefront. The clashes have led some to question the value and even the legitimacy of IP protection. While some of these attacks come from the libertarian perspective, most originate from the same naïve socialist impulses that so demonstrably failed in the realm of real property—but somehow are seen as thoughtful with respect to IP.
IPI believes that creators have the right to own and control the fruits of their creativity, and that the IP system has done an admirable job of not only incentivizing innovation, but also making creative products and services available to the public and transferring technology to the developing world.
Senators John Cornyn and Richard Blumenthal want to control prescription drug prices by empowering bureaucracy. When has that ever worked?
Sen. John Cornyn's legislation that attempts to address problems he sees with the patent protections afforded to American drug companies overreaches and would limit the ability of pharmaceutical firms to develop and improve medicines.
The Institute for Policy Innovation, in partnership with the World Intellectual Property Organization, hosts its annual World Intellectual Property Day Celebration featuring Rep. Doug Collins (R-GA) at 10:00 am on Tuesday, April 30, 2019 at the National Press Club in Washington, D.C.
Coalition letter of over 70 cosigners urging the 116th Congress to protect intellectual property rights for every American innovator.
Innovation continues to outpace government, especially the capacity of legislatures to design sound policy frameworks. The danger is that poor policy will hamper the rollout of smart technology.
Coalition Letter Opposing HHS Advanced Notice of Proposed Rule Making: International Pricing Index Model for Medicare Part B Drugs
In a letter to the Department of Health and Human Services, IPI and 54 other conservative groups and activists expressed opposition to HHS’s “International Pricing Index” payment model for drugs administered under Medicare Part B.
As word of a tentative new trade pact between the U.S. and Mexico surfaced Monday, several associations urged the White House to keep Canada in the agreement too.
The Institute for Policy Innovation has said it is "critical" that "any revision of NAFTA includes strong, updated protections for IP goods and services."
If the new North American Free Trade Agreement (NAFTA) doesn’t improve intellectual property protections, then it’s not a better deal, according to the Institute for Policy Innovation (IPI).